Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Medical Comorbidity Affects Antidepressant Treatment Response in Patients with Melancholic Depression|
|Citation:||Psychotherapy and Psychosomatics, 2009; 78(6):359-363|
|K. Pohle, K. Domschke, T. Roehrs, V. Arolt, B.T. Baune|
|Abstract:||BACKGROUND: This study aimed at the impact of medical comorbidity (MC) on response to antidepressant treatment over 6 weeks in diagnostic subtypes of patients with major depressive episode (MDE). METHODS: In a clinical sample of 241 admitted patients with MDE, MC was assessed by medical specialists and weekly response to antidepressant treatment was assessed with the Hamilton Depression Scale (HAM-D 21). RESULTS: Over 6 weeks of treatment, patients with melancholic depression and MC had poorer treatment response on the HAM-D scale and a worse functional outcome (GAF) as opposed to their counterparts without MC, which was first detected after 4 weeks of treatment (p = 0.02). More specifically, subjects with melancholic depression and cardiovascular or endocrinological MC showed significantly poorer treatment response over 6 weeks. Interestingly, these effects were not related to various antidepressant treatment regimens. CONCLUSIONS: MC has a negative impact on treatment response in patients with melancholic depression.|
|Keywords:||Medical comorbidity; Subtypes of depression; Treatment response|
|Rights:||© 2009 S. Karger AG, Basel|
|Appears in Collections:||Psychiatry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.